Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study

Asia-Pacific Journal of Clinical Oncology

Volumn 11, Issue 3, 2015, Pages e6-e12

  Tan, Xuefen ^a   Xie, Peng ^a   Liu, Jibing ^a   Wu, Huiyong ^a   Xie, Yinfa ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatocellular carcinoma (HCC); Portal vein embolization (PVE); Portal vein tumor thrombus (PVTT); Transcatheter arterial chemoembolization (TACE)

Indexed keywords

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION; FEMALE; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PILOT STUDY; PORTAL VEIN; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84939257483     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12272     Document Type: Article

References (22)

1. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology 2009; 136: 741-754.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
3. Zhou Q, Wang Y, Zhou X etal. Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi. Asian Pac J Cancer Prev 2011; 12: 2847-2850.
4. Yoshidome H, Takeuchi D, Kimura F etal. Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience. J Am Coll Surg 2011; 212: 796-803.
5. Shi J, Lai EC, Li N etal. A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatobiliary Pancreat Sci 2011; 18: 74-80.
6. Liu FY, Wang MQ, Duan F, Fan QS, Song P, Wang Y. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization. BMC Gastroenterol 2013; 13: 105.
7. Dufour JF, Hoppe H, Heim MH etal. Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. Oncologist 2010; 15: 1198-1204.
8. Li H, Hu Y, Li N, Zhou Y. Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. Asian Pac J Cancer Prev 2012; 13: 1589-1593.
9. Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2012; 118: 4725-4736.
10. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
11. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60.
12. Ikai I, Yamaoka Y, Yamamoto Y etal. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998; 227: 433-439.
13. Poon RT, Fan ST, Ng IO, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 2003; 237: 376-383.
14. Pawlik TM, Poon RT, Abdalla EK etal. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005; 137: 403-410.
15. Ikai I, Hatano E, Hasegawa S etal. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 2006; 202: 431-438.
16. Le Treut YP, Hardwigsen J, Ananian P etal. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 2006; 10: 855-862.
17. Nagino M, Nimura Y, Kamiya J etal. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21: 434-439.
18. Kock NG, Hahnloser P, Roding B, Schenk WG Jr. Interaction between portal venous and hepatic arterial blood flow: an experimental study in the dog. Surgery 1972; 72: 414-419.
19. Vauthey JN, Chaoui A, Do KA etal. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-519.
20. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175.
21. Michalopoulos GK, Zarnegar R. Hepatocyte growth factor. Hepatology 1992; 15: 149-155.
22. Duncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP. Embolization of portal vein branches induces hepatocyte hypertrophy in swine: a potential step in hepatic gene therapy. Radiology 1999; 210: 467-477.